Perspectum is an innovative precision health technology company that develops advanced noninvasive diagnostic solutions for healthcare providers. Their mission is to build a better tomorrow for patients through scientific innovation, empowering clinicians and patients to better understand chronic systemic diseases. The company’s technology generates clear, quantitative reports that support clinical decision-making and enhance patient engagement. Founded in 2012 through a partnership with the University of Oxford, Perspectum emerged from a groundbreaking study demonstrating the potential of mul…
Vendor
Perspectum Ltd
Company Website
- Pharma Solutions Platform
Cloud-based imaging platform offering proprietary biomarkers for disease monitoring and analysis in clinical trials.
- CoverScan
The world’s first quantitative imaging solution for the assessment of multi-organ tissue characteristics, function, and size using a single, non-contrast MRI scan. This noninvasive technology can support clinical decision-making by quantifying metrics from images of the heart, liver, lungs, kidneys, pancreas, and spleen.
- Hepatica
Improving accuracy of liver health and volume assessment to support better pre-surgical decision making for patients with liver cancer.
- LiverMultiScan
LiverMultiScan is a noninvasive MRI scan that accurately assesses signs of liver disease, offering a complete picture of liver health.
- MRCP+
MRCP+ provides enhanced visualization and quantitative assessment of the biliary tree and pancreatic duct, based on newly acquired or historic non-contrast MRCP images. This enables physicians to better evaluate and report on hepatobiliary structures for more accurate diagnosis, staging and monitoring of disease.